Authors:
Miglioli, PA
Allerberger, F
Calabro, GB
Gaion, RM
Citation: Pa. Miglioli et al., Effects of daily oral administration of rifaximin and neomycin on faecal aerobic flora in rats, PHARMAC RES, 44(5), 2001, pp. 373-375
Authors:
Fischer, H
Konig, P
Dierich, MP
Allerberger, F
Citation: H. Fischer et al., Hemolytic-uremic syndrome surveillance to monitor trends in infection withEscherichia coli O157 and non-O157 enterohemorrhagic E-coli in Austria, PEDIAT INF, 20(3), 2001, pp. 316-318
Authors:
Grif, K
Dierich, MP
Pfaller, K
Miglioli, PA
Allerberger, F
Citation: K. Grif et al., In vitro activity of fosfomycin in combination with various antistaphylococcal substances, J ANTIMICRO, 48(2), 2001, pp. 209-217
Authors:
Grif, K
Hein, I
Wagner, M
Brandl, E
Mpamugo, O
McLauchlin, J
Dierich, MP
Allerberger, F
Citation: K. Grif et al., Prevalence and characterization of Listeria monocytogenes in the feces of healthy Austrians, WIEN KLIN W, 113(19), 2001, pp. 737-742
Authors:
Brandt, CM
Allerberger, F
Spellerberg, B
Holland, R
Lutticken, R
Haase, G
Citation: Cm. Brandt et al., Characterization of consecutive Streptococcus pyogenes isolates from patients with pharyngitis and bacteriological treatment failure: Special reference to prtF1 and sic/drs, J INFEC DIS, 183(4), 2001, pp. 670-674
Authors:
Bujdakova, H
Klimackova, J
Allerberger, F
Moravcikova, M
Bagova, M
Hanzen, J
Michalkova-Papajova, D
Dierich, MP
Kettner, M
Citation: H. Bujdakova et al., Spectrum and transferability of beta-lactam resistance in hospital strainsof Enterobacter isolated in Bratislava and Innsbruck, INT J ANT A, 16(1), 2000, pp. 31-36
Authors:
Mellmann, A
Orth, D
Dierich, MP
Allerberger, F
Klare, I
Witte, W
Citation: A. Mellmann et al., Nosocomial cross transmission as a primary cause of vancomycin-resistant enterococci in Austria, J HOSP INF, 44(4), 2000, pp. 281-287
Authors:
Krugmann, J
Sailer-Hock, M
Muller, T
Gruber, J
Allerberger, F
Offner, FA
Citation: J. Krugmann et al., Epstein-Barr virus-associated Hodgkin's lymphoma and Legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cyclosporine A, HUMAN PATH, 31(2), 2000, pp. 253-255
Authors:
Allerberger, F
Dierich, MP
Gruber-Moesenbacher, U
Liesegang, A
Prager, R
Hartmann, G
Rabsch, W
Tschape, H
Karch, H
Citation: F. Allerberger et al., Nontoxigenic sorbitol-fermenting Escherichia coli O157 : H- associated with a family outbreak of diarrhoea, WIEN KLIN W, 112(19), 2000, pp. 846-850
Authors:
Miglioli, PA
Silini, R
Carzeri, O
Grabocka, E
Allerberger, F
Citation: Pa. Miglioli et al., Antibacterial activity of gentamicin and ciprofloxacin against gram-negative bacteria: Interactions with pig and calf sera, PHARMAC RES, 39(4), 1999, pp. 321-323
Authors:
Verweyen, HM
Karch, H
Allerberger, F
Zimmerhackl, LB
Citation: Hm. Verweyen et al., Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic-uremic syndrome: A prospective study in Germany and Austria, INFECTION, 27(6), 1999, pp. 341-347
Citation: F. Allerberger et Sj. Fritschel, Use of automated ribotyping of Austrian Listeria monocytogenes isolates tosupport epidemiological typing, J MICROB M, 35(3), 1999, pp. 237-244
Authors:
Pavlic, M
Allerberger, F
Dierich, MP
Prodinger, WM
Citation: M. Pavlic et al., Simultaneous infection with two drug-susceptible Mycobacterium tuberculosis strains in an immunocompetent host, J CLIN MICR, 37(12), 1999, pp. 4156-4157
Citation: Ec. Reisinger et F. Allerberger, Bacterial resistance, beta-lactam antibiotics and gramnegative bacteria atICUs, WIEN KLIN W, 111(14), 1999, pp. 537-538
Authors:
Krause, R
Mittermayer, H
Feierl, G
Allerberger, F
Wendelin, I
Hirschl, A
Reisinger, EC
Citation: R. Krause et al., In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: A report from Austrian Intensive Care Units, WIEN KLIN W, 111(14), 1999, pp. 549-554
Authors:
Morabito, S
Karch, H
Schmidt, H
Minelli, F
Mariani-Kurkdjian, P
Allerberger, F
Bettelheim, KA
Caprioli, A
Citation: S. Morabito et al., Molecular characterisation of verocytotoxin-producing Escherichia coli of serogroup O111 from different countries, J MED MICRO, 48(10), 1999, pp. 891-896
Authors:
Grif, K
Dierich, MP
Karch, H
Allerberger, F
Citation: K. Grif et al., Strain-specific differences in the amount of shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents, EUR J CL M, 17(11), 1998, pp. 761-766
Authors:
Jakob-Solder, B
Steininger, C
Eigentler, A
Allerberger, F
Citation: B. Jakob-solder et al., Treatment of pediatric patients with acute group A beta-hemolytic Streptococcal tonsillopharyngitis, EUR J CL M, 17(11), 1998, pp. 811-812
Authors:
Miglioli, PA
Allerberger, F
Walderberg, I
Hasse, J
Citation: Pa. Miglioli et al., Antibacterial activity of human pleural fluid: alone and in combination with antibiotics., INT J ANT A, 10(4), 1998, pp. 317-319